Search Results - "Korbling, Martin"

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation by Gaballa, Sameh, Ge, Isabell, El Fakih, Riad, Brammer, Jonathan E., Kongtim, Piyanuch, Tomuleasa, Ciprian, Wang, Sa A., Lee, Dean, Petropoulos, Demetrios, Cao, Kai, Rondon, Gabriela, Chen, Julianne, Hammerstrom, Aimee, Lombardi, Lindsey, Alatrash, Gheath, Korbling, Martin, Oran, Betul, Kebriaei, Partow, Ahmed, Sairah, Shah, Nina, Rezvani, Katayoun, Marin, David, Bashir, Qaiser, Alousi, Amin, Nieto, Yago, Qazilbash, Muzaffar, Hosing, Chitra, Popat, Uday, Shpall, Elizabeth J., Khouri, Issa, Champlin, Richard E., Ciurea, Stefan O.

“…BACKGROUND High‐dose, post‐transplantation cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) has improved outcomes in haploidentical (HAPLO)…”
Get full text

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma by Tam, Constantine S., Bassett, Roland, Ledesma, Celina, Korbling, Martin, Alousi, Amin, Hosing, Chitra, Kebraei, Partow, Harrell, Robyn, Rondon, Gabriela, Giralt, Sergio A., Anderlini, Paolo, Popat, Uday, Pro, Barbara, Samuels, Barry, Hagemeister, Frederick, Medeiros, L. Jeffrey, Champlin, Richard E., Khouri, Issa F.

“…In this study, we analyzed the long-term outcome of a risk-adapted transplantation strategy for mantle cell lymphoma in 121 patients enrolled in sequential…”
Get full text

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS by de Lima, Marcos, Couriel, Daniel, Thall, Peter F., Wang, Xuemei, Madden, Timothy, Jones, Roy, Shpall, Elizabeth J., Shahjahan, Munir, Pierre, Betty, Giralt, Sergio, Korbling, Martin, Russell, James A., Champlin, Richard E., Andersson, Borje S.

“…Postulating favorable antileukemic effect with improved safety, we used intravenous busulfan and fludarabine as conditioning therapy for allogeneic…”
Get full text

Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma by Chahoud, Jad, Sui, Dawen, Erwin, William D., Gulbis, Alison M., Korbling, Martin, Zhang, Mingzhi, Ahmed, Sairah, Alatrash, Gheath, Anderlini, Paolo, Ciurea, Stefan O., Oran, Betul, Fayad, Luis E., Bassett, Roland L., Jabbour, Elias J., Medeiros, L. Jeffrey, Macapinlac, Homer A., Young, Ken H., Khouri, Issa F.

“…Abstract Purpose: We evaluated the effect on long-term survival of adding rituximab (R) to BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning…”
Get full text

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality by Khouri, Issa F., Saliba, Rima M., Giralt, Sergio A., Lee, Ming-Sheng, Okoroji, Grace-Julia, Hagemeister, Fredrick B., Korbling, Martin, Younes, Anas, Ippoliti, Cindy, Gajewski, James L., McLaughlin, Peter, Anderlini, Paolo, Donato, Michele L., Cabanillas, Fernando F., Champlin, Richard E.

“…This study investigated the use of a nonablative conditioning regimen to decrease toxicity and achieve engraftment of an allogeneic blood stem cell transplant,…”
Get full text

Concurrent Administration of High-Dose Rituximab Before and After Autologous Stem-Cell Transplantation for Relapsed Aggressive B-Cell Non-Hodgkin’s Lymphomas by Khouri, Issa F, Saliba, Rima M, Hosing, Chitra, Okoroji, Grace-Julia, Acholonu, Sandra, Anderlini, Paolo, Couriel, Daniel, De Lima, Marcos, Donato, Michele L, Fayad, Luis, Giralt, Segio, Jones, Roy, Korbling, Martin, Maadani, Farzaneh, Manning, John T, Pro, Barbara, Shpall, Elizabeth, Younes, Anas, McLaughlin, Peter, Champlin, Richard E

“…We investigated the efficacy and safety of administering high-dose rituximab (HD-R) in combination with high-dose carmustine, cytarabine, etoposide, and…”
Get full text

Twenty-five years of peripheral blood stem cell transplantation by Körbling, Martin, Freireich, Emil J

“…Peripheral blood stem cell transplantation (PBSCT) is the most common transplantation procedure performed in medicine. Its clinical introduction in 1986…”
Get full text

Adult stem cells for tissue repair: A new therapeutic concept? by KÖRBLING, Martin, ESTROV, Zeev

Get full text

Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? by Körbling, Martin, Anderlini, Paolo

“…Hematopoietic stem cells from 4 different sources have been or are being used for the reconstitution of lymphohematopoietic function after myeloablative,…”
Get full text

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation by Ciurea, Stefan O., Thall, Peter F., Wang, Xuemei, Wang, Sa A., Hu, Ying, Cano, Pedro, Aung, Fleur, Rondon, Gabriela, Molldrem, Jeffrey J., Korbling, Martin, Shpall, Elizabeth J., de Lima, Marcos, Champlin, Richard E., Fernandez-Vina, Marcelo

“…Anti-HLA donor-specific Abs (DSAs) have been reported to be associated with graft failure in mismatched hematopoietic stem cell transplantation; however, their…”
Get full text

Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo by YEH, Edward T. H, SUI ZHANG, WU, Henry D, KÖRBLING, Martin, WILLERSON, James T, ESTROV, Zeev

“…Adult human peripheral blood cells have been shown to differentiate into mature cells of nonhematopoietic tissues, such as hepatocytes and epithelial cells of…”
Get full text

Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells by Körbling, Martin, Katz, Ruth L, Khanna, Abha, Ruifrok, Arnout C, Rondon, Gabriela, Albitar, Maher, Champlin, Richard E, Estrov, Zeev

“…Male cells were sought in biopsy specimens of liver, skin, and gastrointestinal tract from six women who received a transplant of peripheral-blood stem cells…”
Get full text

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation by Khouri, Maria R, Jabbour, Elias J, Gulbis, Alison M, Turturro, Francesco, Ledesma, Celina, Korbling, Martin, Samuels, Barry I, Ahmed, Sairah, Alousi, Amin M, Ciurea, Stefan O, Marin, David, Patel, Krina K, Popat, Uday R, Bueso-Ramos, Carlos E, Bassett, Roland L, Khouri, Issa F

“…Abstract In patients with chronic lymphocytic leukemia (CLL), persistence of disease after allogeneic stem cell transplantation (alloSCT) can result in poor…”
Get full text

Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma by Hosing, Chitra, Saliba, Rima M., Ahlawat, Sheena, Körbling, Martin, Kebriaei, Partow, Alousi, Amin, De Lima, Marcos, Okoroji, Julia‐Grace, McMannis, John, Qazilbash, Muzaffar, Anderlini, Paolo, Giralt, Sergio, Champlin, Richard E., Khouri, Issa, Popat, Uday

“…The purpose of this retrospective study was to determine the incidence and predictive factors if any, of mobilization failure in lymphoma patients referred for…”
Get full text

Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture by de Lima, Marcos, McNiece, Ian, Robinson, Simon N, Munsell, Mark, Eapen, Mary, Horowitz, Mary, Alousi, Amin, Saliba, Rima, McMannis, John D, Kaur, Indreshpal, Kebriaei, Partow, Parmar, Simrit, Popat, Uday, Hosing, Chitra, Champlin, Richard, Bollard, Catherine, Molldrem, Jeffrey J, Jones, Roy B, Nieto, Yago, Andersson, Borje S, Shah, Nina, Oran, Betul, Cooper, Laurence J.N, Worth, Laura, Qazilbash, Muzaffar H, Korbling, Martin, Rondon, Gabriela, Ciurea, Stefan, Bosque, Doyle, Maewal, Ila, Simmons, Paul J, Shpall, Elizabeth J

“…Use of 2 units of cord blood, 1 of which had been cocultured with mesenchymal stem cells, produced more rapid hematopoietic engraftment than 2 units of…”
Get full text

High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation by CIUREA, Stefan O, DE LIMA, Marcos, CANO, Pedro, KORBLING, Martin, GIRALT, Sergio, SHPALL, Elizabeth J, XUEMEI WANG, THALL, Peter F, CHAMPLIN, Richard E, FERNANDEZ-VINA, Marcelo

“…BACKGROUND.: Although donor-specific anti-human leukocyte antigen (HLA) antibodies (DSA) have been implicated in graft rejection in solid organ…”
Get full text

Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis by Körbling, Martin, Reuben, James M., Gao, Hui, Lee, Bang-Ning, Harris, David M., Cogdell, David, Giralt, Sergio A., Khouri, Issa F., Saliba, Rima M., Champlin, Richard E., Zhang, Wei, Estrov, Zeev

“…BACKGROUND: Endothelial progenitor cells (EPCs) have been identified among hematopoietic tissue‐derived progenitor cells that are mobilized into the peripheral…”
Get full text

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy by Giralt, Sergio, Estey, Elihu, Albitar, Maher, van Besien, Koen, Rondón, Gabriela, Anderlini, Paolo, O'Brien, Susan, Khouri, Issa, Gajewski, James, Mehra, Rakesh, Claxton, David, Andersson, Borje, Beran, Miloslav, Przepiorka, Donna, Koller, Charles, Kornblau, Steve, Körbling, Martin, Keating, Michael, Kantarjian, Hagop, Champlin, Richard

“…The immune-mediated graft-versus-leukemia effect is important to prevent relapse after allogeneic progenitor cell transplantation. This process requires…”
Get full text

Transplant-Associated Microangiopathy in Patients Receiving Tacrolimus Following Allogeneic Stem Cell Transplantation: Risk Factors and Response to Treatment by Oran, Betul, Donato, Michele, Aleman, Ana, Hosing, Chitra, Korbling, Martin, Detry, Michelle A, Wei, Caimiao, Anderlini, Paolo, Popat, Uday, Shpall, Elizabeth, Giralt, Sergio, Champlin, Richard E

“…Abstract Transplant-associated microangiopathy (TAM) is a life-threatening complication after allogeneic HSCT, particularly with the use of calcineurin…”
Get full text

Early Detection of Relapse by Hypermetaphase Fluorescence In Situ Hybridization After Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia by SEONG, C.-M, GIRALT, S, SICILIANO, M. J, CHAMPLIN, R. E, KANTARJIAN, H, JINGPING XU, SWANTKOWSKI, J, HAYES, K, GLASSMAN, A. B, KHOURI, I, KORBLING, M, THALL, P

“…Standard G-band cytogenetic analysis (CG) provides information on approximately 25 metaphases for monitoring the presence of Philadelphia chromosome positive…”
Get full text